A detailed history of Stephens Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Stephens Inc holds 5,059 shares of EW stock, worth $460,773. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,059
Previous 23,191 78.19%
Holding current value
$460,773
Previous $1.77 Million 72.68%
% of portfolio
0.01%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $1.32 Million - $1.73 Million
-18,132 Reduced 78.19%
5,059 $483,000
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $27,769 - $34,992
-450 Reduced 1.9%
23,191 $1.77 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $29,651 - $39,966
-428 Reduced 1.78%
23,641 $1.64 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $1,465 - $1,697
-18 Reduced 0.07%
24,069 $2.27 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $13,515 - $15,380
-182 Reduced 0.75%
24,087 $1.99 Million
Q4 2022

Jan 25, 2023

SELL
$68.3 - $87.44 $348,125 - $445,681
-5,097 Reduced 17.36%
24,269 $1.81 Million
Q3 2022

Nov 02, 2022

BUY
$82.37 - $107.29 $382,526 - $498,254
4,644 Added 18.78%
29,366 $2.43 Million
Q2 2022

Aug 03, 2022

BUY
$86.5 - $128.27 $20,760 - $30,784
240 Added 0.98%
24,722 $2.35 Million
Q1 2022

May 04, 2022

SELL
$101.96 - $128.34 $191,073 - $240,509
-1,874 Reduced 7.11%
24,482 $2.88 Million
Q4 2021

Mar 07, 2022

SELL
$106.37 - $130.68 $57,439 - $70,567
-540 Reduced 2.01%
26,356 $3.41 Million
Q3 2021

Oct 27, 2021

BUY
$102.91 - $122.75 $41,678 - $49,713
405 Added 1.53%
26,896 $3.05 Million
Q2 2021

Aug 12, 2021

BUY
$83.84 - $104.76 $43,345 - $54,160
517 Added 1.99%
26,491 $2.74 Million
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $1.44 Million - $1.66 Million
18,282 Added 237.68%
25,974 $2.17 Million
Q4 2020

Feb 10, 2021

SELL
$71.69 - $91.23 $1.3 Million - $1.65 Million
-18,102 Reduced 70.18%
7,692 $702,000
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $5,912 - $7,694
88 Added 0.34%
25,794 $2.06 Million
Q2 2020

Aug 24, 2020

BUY
$57.54 - $76.95 $1.03 Million - $1.38 Million
17,926 Added 230.41%
25,706 $1.78 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $318,705 - $492,561
6,081 Added 357.92%
7,780 $1.47 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $414,641 - $474,726
-5,783 Reduced 77.29%
1,699 $396,000
Q3 2019

Oct 18, 2019

BUY
$61.55 - $75.43 $2,769 - $3,394
45 Added 0.61%
7,482 $1.65 Million
Q2 2019

Aug 01, 2019

SELL
$55.74 - $64.41 $445 - $515
-8 Reduced 0.11%
7,437 $1.37 Million
Q1 2019

May 03, 2019

SELL
$47.89 - $64.05 $7,422 - $9,927
-155 Reduced 2.04%
7,445 $1.42 Million
Q4 2018

Feb 11, 2019

SELL
$46.41 - $56.94 $94,212 - $115,588
-2,030 Reduced 21.08%
7,600 $1.16 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $440,091 - $558,828
9,630 New
9,630 $1.68 Million
Q3 2017

Nov 08, 2017

SELL
$36.29 - $38.83 $284,186 - $304,077
-7,831 Closed
0 $0
Q2 2017

Aug 10, 2017

BUY
N/A
7,831
7,831 $926,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $56.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Stephens Inc Portfolio

Follow Stephens Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.